AstraZeneca, Daiichi Sankyo replace lung cancer filing for Enhertu successornews2024-11-12T12:21:18+00:00November 12th, 2024|Endpoints News|
AstraZeneca budgets another $2B to boost manufacturing and R&D in USnews2024-11-12T12:08:44+00:00November 12th, 2024|Endpoints News|
Sanofi, OpenAI, Formation Bio launch Muse, an AI tool for patient recruitmentnews2024-11-12T12:00:23+00:00November 12th, 2024|Endpoints News|
Novartis pays $150M upfront to Schrödinger in new drug dealnews2024-11-12T11:50:06+00:00November 12th, 2024|Endpoints News|
Neurogene’s stock falls in post-market trading after early data in Rett syndromenews2024-11-12T05:16:30+00:00November 12th, 2024|Endpoints News|
FDA lifts hold on Novavax vaccines after adverse event reclassified as ALSnews2024-11-11T18:25:04+00:00November 11th, 2024|Endpoints News|
Yorvipath’s approval showcases biopharma’s interest in rare endocrine disordernews2024-11-11T16:15:06+00:00November 11th, 2024|Endpoints News|
Assertio considers legal options against activist investor accusing company of fraudnews2024-11-11T16:04:30+00:00November 11th, 2024|Endpoints News|
AbbVie’s schizophrenia drug from Cerevel fails two Phase 2 trialsnews2024-11-11T15:47:26+00:00November 11th, 2024|Endpoints News|
Amgen and AstraZeneca share positive results in chronic rhinosinusitisnews2024-11-08T19:30:06+00:00November 8th, 2024|Endpoints News|
